These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 15958130

  • 1. Harmful effects of anti-GalNAc-GD1a antibodies and TNF-alpha on rat dorsal root ganglia.
    Kamakura K, Kaida K, Kusunoki S, Miyamoto N, Masaki T, Nakamura R, Motoyoshi K, Fukuda J.
    J Peripher Nerv Syst; 2005 Jun; 10(2):190-201. PubMed ID: 15958130
    [Abstract] [Full Text] [Related]

  • 2. Neurophysiological and immunohistochemical studies on Guillain-Barre syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission.
    Taguchi K, Ren J, Utsunomiya I, Aoyagi H, Fujita N, Ariga T, Miyatake T, Yoshino H.
    J Neurol Sci; 2004 Oct 15; 225(1-2):91-8. PubMed ID: 15465091
    [Abstract] [Full Text] [Related]

  • 3. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
    Odaka M, Yuki N, Tatsumoto M, Tateno M, Hirata K.
    J Neurol; 2004 Jan 15; 251(1):24-9. PubMed ID: 14999485
    [Abstract] [Full Text] [Related]

  • 4. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K, Sonoo M, Ogawa G, Kamakura K, Ueda-Sada M, Arita M, Motoyoshi K, Kusunoki S.
    Neurology; 2008 Nov 18; 71(21):1683-90. PubMed ID: 19015484
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.
    Ogawa G, Kaida K, Kuwahara M, Kimura F, Kamakura K, Kusunoki S.
    J Neuroimmunol; 2013 Jan 15; 254(1-2):141-5. PubMed ID: 23000056
    [Abstract] [Full Text] [Related]

  • 9. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N.
    Ann Neurol; 2000 Oct 15; 48(4):624-31. PubMed ID: 11026446
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K, Kamakura K, Ogawa G, Ueda M, Motoyoshi K, Arita M, Kusunoki S.
    Neurology; 2008 Jul 15; 71(3):196-201. PubMed ID: 18625966
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-GalNAc-GD1a antibody-associated Guillain-Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance.
    Hao Q, Saida T, Yoshino H, Kuroki S, Nukina M, Saida K.
    Ann Neurol; 1999 Jun 15; 45(6):758-68. PubMed ID: 10360768
    [Abstract] [Full Text] [Related]

  • 14. [Clinical features of neuropathies in a group of patients associated with anti-GalNAc-GD1a antibody].
    Tatsumoto M, Odaka M, Koga M, Hirata K, Yuki N.
    Rinsho Shinkeigaku; 2004 Aug 15; 44(8):508-12. PubMed ID: 15471085
    [Abstract] [Full Text] [Related]

  • 15. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome.
    Yuki N, Yamada M, Sato S, Ohama E, Kawase Y, Ikuta F, Miyatake T.
    Muscle Nerve; 1993 Jun 15; 16(6):642-7. PubMed ID: 8502262
    [Abstract] [Full Text] [Related]

  • 16. GalNAc-GD1a in human peripheral nerve: target sites of anti-ganglioside antibody.
    Kaida K, Kusunoki S, Kamakura K, Motoyoshi K, Kanazawa I.
    Neurology; 2003 Aug 26; 61(4):465-70. PubMed ID: 12939418
    [Abstract] [Full Text] [Related]

  • 17. Anti-GD1a ganglioside antibodies in peripheral motor syndromes.
    Carpo M, Nobile-Orazio E, Meucci N, Gamba M, Barbieri S, Allaria S, Scarlato G.
    Ann Neurol; 1996 Apr 26; 39(4):539-43. PubMed ID: 8619533
    [Abstract] [Full Text] [Related]

  • 18. Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies.
    Ang CW, Yuki N, Jacobs BC, Koga M, Van Doorn PA, Schmitz PI, Van Der Meché FG.
    Neurology; 1999 Dec 10; 53(9):2122-7. PubMed ID: 10599792
    [Abstract] [Full Text] [Related]

  • 19. The first total synthesis of ganglioside GalNAc-GD1a, a target molecule for autoantibodies in Guillain-Barré syndrome.
    Fujikawa K, Nakashima S, Konishi M, Fuse T, Komura N, Ando T, Ando H, Yuki N, Ishida H, Kiso M.
    Chemistry; 2011 May 09; 17(20):5641-51. PubMed ID: 21469228
    [Abstract] [Full Text] [Related]

  • 20. Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a.
    Mauri L, Casellato R, Ciampa MG, Uekusa Y, Kato K, Kaida K, Motoyama M, Kusunoki S, Sonnino S.
    Glycobiology; 2012 Mar 09; 22(3):352-60. PubMed ID: 21921061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.